Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

According to FDA, Hurricane Helen caused a supply disruption of IV solutions from Baxter’s facility in North Carolina.

Health authorities say they are continuing to manage the shortage and supply of IV fluids as a priority. Doctors are fighting ...

ICU Medical (NASDAQ:ICUI) and Otsuka Pharmaceutical Factory, a unit of Japan’s Otsuka, are launching a joint venture focused ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

When Hurricane Milton barreled through the Gulf of Mexico with a ferocity that brought one Florida-based meteorologist to tears, Beth Gore’s biggest worry wasn’t ...

As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...